Company Filing History:
Years Active: 1989
Title: Cheryl Black: Innovator in Pharmaceutical Composition
Introduction
Cheryl Black is a notable inventor based in Vernon Hills, IL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of stable pharmaceutical compositions for cardiac treatment. Her innovative work has the potential to enhance patient care and improve treatment outcomes.
Latest Patents
Cheryl Black holds a patent for a stable pharmaceutical composition. This injectable, aqueous pharmaceutical composition is designed for the treatment of cardiac conditions. It comprises an effective amount of methyl 3-[4-(2-hydroxy-3-isopropylamino)propoxy]phenylpropionate hydrochloride, commonly known as esmolol. The composition includes about 1 mg to 250 mg of esmolol per milliliter, along with a buffer concentration of 0.01 to 0.02M. The pH range of the composition is maintained between 4.5 to 5.5, which enhances the stability of esmolol in an aqueous solution.
Career Highlights
Cheryl Black is associated with E.I. DuPont de Nemours and Company, where she has contributed her expertise in pharmaceutical development. Her work focuses on creating compositions that improve the stability and efficacy of medications used in treating cardiac conditions.
Collaborations
Cheryl has collaborated with notable colleagues, including Leonard S. Rosenberg and Earl R. Speicher. These collaborations have furthered her research and development efforts in the pharmaceutical industry.
Conclusion
Cheryl Black's innovative contributions to pharmaceutical compositions demonstrate her commitment to advancing medical treatments. Her patent for a stable injectable composition showcases her expertise and dedication to improving cardiac care.